Business Description
Hepion Pharmaceuticals (OTCQB: HEPA) is pioneering early cancer detection solutions with novel advanced liquid biopsy diagnostics. Leveraging deep expertise in liver biology, Hepion acquired complementary platforms for precise diagnosis of early hepatocellular carcinoma (HCC) in people with cirrhosis – a clinically validated methylated DNA (SEPT9) biomarker test for near-term commercialization, and a circulating tumor RNA (ctRNA) biomarker assay with potential application across a variety of solid tumors. With a clear roadmap from Clinical Laboratory Improvement Amendments (CLIA) launch to U.S. Food and Drug Administration (FDA) approval and multiple partnership pathways, Hepion is positioned to transform how solid tumors are detected and monitored in high-risk patients.
Corporate Presentation
Coming Soon!
IR Contacts
Transfer Agent
Bob Winterle
Philadelphia Stock Transfer
Phone: 866-223-0448
Email: bwinterle@philadelphiastocktransfer.com
Auditor
BDO USA, LLP
100 Park Avenue
New York, NY 10017
Phone: 212-885-8000
U.S. Legal Council
Jeffrey J. Fessler
Sheppard Mullin
30 Rockefeller Plaza
New York, NY 10112
Industry Classifications
Sector
Manufacturing
Industry
Pharmaceutical Preparations
SIC
2834
Frequently Asked Questions
Can I buy stock directly from Hepion?
No, you will need to contact a licensed stock broker or use an online trading account.
How can I buy stock in Hepion?
Through a licensed stock broker or by using an online trading account.
How do I get my purchased shares?
Contact Hepion’s transfer agent Bob Winterle of Philadelphia Stock Transfer at 866-223-0448 or by email at bwinterle@philadelphiastocktransfer.com.
What is Hepion’s CUSIP number?
426897104
Whom can I contact for general information about Hepion?
Contact info@hepionpharma.com.
When was Hepion founded?
Hepion Pharmaceuticals (formerly ContraVir Pharmaceuticals) was spun-off from Synergy Pharmaceuticals in 2014 through a SEC Form 10 filing.
What is Hepion’s mailing address?
5 Madison Avenue, Suite 400, PMB #4362, Morristown, NJ 07960
When is Hepion’s fiscal year end?
December 31st
Who are Hepion’s independent auditors?
Hepion’s auditors are BDO USA, LLP.
Who is Hepion’s outside legal counsel?
Hepion’s outside legal counsel is Jeffrey J. Fessler, a partner in the Corporate Practice at Sheppard Mullin in New York, NY.